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ABSTRACT
Collagen type I represents a novel material for three-dimensional in vitro
models. While two-dimensional models are typically inadequate for recreating the
complex processes of the body, collagen provides a three-dimensional basis with
a variety of applications, including remodeling of vascular cells under tension and
vascular stenosis. Smooth muscle cells reorganize and reconstruct their
environment differently under conditions of tensions, such as with sutures, or under
conditions without applied external tension. Vascular stenosis, the abnormal
narrowing of blood vessels, arises from defective developmental processes or
atherosclerosis-related adult pathologies. Stenosis triggers a series of adaptive
cellular responses that induces adverse remodeling, which can progress to partial
or complete vessel occlusion with numerous fatal outcomes. Despite its severity,
the cellular interactions and biophysical cues that regulate this pathological
progression are poorly understood. Here, we report the design and fabrication of
a three-dimensional (3D) in vitro system to model cellular tension from sutures and
vascular stenosis so that specific cellular interactions and responses to
hemodynamic stimuli can be investigated. Tubular cellularized constructs
(cytotubes) were produced, using a collagen casting system, to generate a straight
cylindrical model in addition to stenotic arterial model. Spatial distribution of cells
remained more even in cylindrical cytotubes that were sutured compared to those
without applied tension. Fabrication methods were developed to create cytotubes
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containing single- and co-cultured vascular cells, where cell viability, distribution,
morphology, and contraction were examined. Fibroblasts, bone marrow primary
cells, smooth muscle cells (SMCs), and endothelial cells (ECs) remained viable
during culture and developed location- and time-dependent morphologies. We
found stenotic cytotube contraction to depend on cellular composition, where
SMC-EC co-cultures adopted intermediate contractile phenotypes between SMCand EC-only cytotubes. Our fabrication approach and the resulting in vitro and
artery models can serve as 3D culture systems to investigate vascular
pathogenesis and promote the tissue engineering field.
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CHAPTER 1
INTRODUCTION1
Vascular stenosis is a common condition broadly characterized as
abnormal blood vessel narrowing, which results in increased resistance to blood
flow. During development, this process can have major implications for overall
cardiovascular health in conditions such as supravalvular aortic stenosis.1,2 While
vascular stenosis can occur in arteries and veins, it occurs mostly in medium- and
large-sized arteries.3 Vascular stenosis also refers to the geometry of an artery
and is not a disease in and of itself but can be triggered or caused by an underlying
disease or defects in the tissue. It can also arise as a result of interventions such
as transannular patch repair, which is known to cause left pulmonary artery
stenosis in patients with tetralogy of Fallot.4 Alternatively, atherosclerotic
conditions such as carotid artery disease, peripheral artery disease, or renal artery
disease are characterized by plaque accumulation resulting in significant luminal
narrowing.5–7 Atherosclerosis is a precursor and major risk factor for the majority
of acute coronary syndromes (ACS), which are triggered by sudden drops in blood
flow to the heart and often lead to death or severe complications. These events

1

Parts of this chapter have been excerpted from the following research article:
1. Jones RS, Chang PH, Perahia T, et al. Design and Fabrication of a ThreeDimensional in Vitro System for Modeling Vascular Stenosis. Microsc
Microanal. 2017;23(4):859-871. doi:10.1017/S1431927617012302

1

are also classified under the category of general cardiovascular disease (CVD),
which accounted for 788,000 deaths in 2010 or 32 percent of overall deaths in the
United States for that year. Coronary heart disease, a subcategory of CVD that is
more specifically linked to atherosclerosis, was the predominant form of CVD in
2010, resulting in 380,000 of the 788,000 CVD deaths. In total, atherosclerosisrelated diseases were responsible for 68% of CVD deaths in 2010.8 According to
the American Heart Association, CVD accounted for 30.8 percent of overall deaths
in the United States in 2013, or approximately one death every 40 seconds, with
46.2% attributed to coronary heart disease resulting in about one out of every
seven deaths.
In order to reduce the prevalence and mortality of atherosclerosis and its
related diseases, the sequence of events leading to the development and
escalation of atherosclerosis must be better defined so that researchers can derive
efficient preventive measures and treatments for clinicians. Many years of
research have contributed to the current depth of knowledge for this disease, yet
the precise process and pathways in which atherosclerosis appears and
progresses remain ambiguous and vague.
In recent years, the biomechanical forces from blood flow within arteries
have gained more recognition as key determining factors in the location and the
likelihood of occurrence for atherogenesis.9,10 Further investigation into these
biomechanical forces in relation to atherosclerosis may help define the
mechanisms through which the disease initiates and progresses. Biomechanical
stimuli were previously thought to play very minor roles in biological phenomena
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and to have few effects on chemical signaling and other phenomena.11,12 Recent
research in this area and other areas of biology has proven that biomechanical
stimuli and cellular mechanotransduction play a much larger role in mechanical
and chemical cellular signaling and behavior than scientists had previously
believed.12
As blood flows through arteries, the viscous property of blood exerts a force
upon the layer of endothelial cells that comprise the innermost layer of the vessel
wall called the tunica intima. This tangential frictional force, measured in Pascals
(Pa) or Newtons per meter squared (N/m2), on the intimal layer is referred to as
wall shear stress (WSS) or endothelial shear stress (ESS) and occurs as a result
of blood flowing across the endothelial cell layer.10,12 Wall shear stress (tw) is
represented as the product of the blood viscosity and the velocity gradient at the
%&

wall in the radial direction (𝜏" = 𝜇 %' ).10,13 Pulsatile pressures normal to the blood
flow confer cyclic stretching within the vessel wall that is also referred to as cyclic
strain, which then induces a circumferential stress upon the vessel wall.12,14
Smooth muscle cells (SMCs) and elastic and collagen fibers located in the medial
layer of the vessel wall supply the mechanical strength of the arterial wall, thereby
accommodating the circumferential stress and cyclic strain forces, while the outer
adventitial vessel layer, composed of mainly fibroblasts and collagenous fibers,
contributes to wall reinforcement.14,15 Animal models of surgically induced aortic
stenosis have also been used to investigate the transient, proximal and distal
effects of altered hemodynamics.16,17 The increased resistance to flow raises blood
pressure, causing cardiac hypertrophy, while local downstream flow disturbances
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also exacerbate stenosis progression provoking further stenosis and vascular
damage.7,18,19 Despite the wide variety in etiology, a common series of sequelae
occurs in vascular pathology, which is characterized by remodeling of the
extracellular matrix and excessive smooth muscle proliferation.5,19 Without
intervention, this pathology will progress, leading to critical stenosis, occlusion,
and, potentially, vessel rupture.6,7 Though the general outcomes of this
progression are well characterized, numerous aspects of the mechanistic cell–cell
interactions that drive vascular pathology and its progression are unknown.
While in vivo investigations appear to be ideal, multi- organ system
responses and subject-to-subject anatomical and physiological variation
complicate analysis and interpretation. Alternatively, in vitro experiments using
standard two-dimensional cell culture fail to adequately model the complex, in vivo,
tissue behaviors of blood vessels.20 Endothelial cell (EC) activation, smooth
muscle cell (SMC) proliferation, and extracellular matrix (ECM) remodeling appear
to be part of a concerted pathological process that involves each of the
representative vascular cells, including ECs, SMCs, and fibroblasts (FBs), through
multifactorial and heterotypic cell signaling cascades.20,21 Thus, the purpose of this
study was to generate an in vitro, three-dimensional (3D) arterial model capable of
supporting the growth and development of an array of characteristic vascular cells
in an environment that can provide dynamic mechanical stimuli.
Nearly 35 years ago, a type I collagen-based blood vessel model was
proposed as a novel material for an in vitro blood vessel model.22 Type I collagen
is the most abundant type of collagen in the adult human connective tissues, thus
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it seems like a logical choice when attempting to generate 3D models that recreate
conditions in the body. Since then, type I collagen has been utilized for countless
in vitro tissue models, not limited to applications for the cardiovascular field,
connective tissues, mesenchymal stem cells, and many others.23–25
In previous studies, we generated a variety of 3D models of cardiovascular
tissues using a variety of fabrication techniques.26–28 More recently, a dynamic fluid
flow bioreactor system was used in conjunction with a tubular collagen scaffold to
investigate the mechanisms that regulate hemodynamic-driven remodeling in
developing valve tissues.29,30 During development, hemodynamic stimuli regulate
remodeling in the cardiovascular valve tissues and also in the early vasculature in
the mammalian yolk sac.31 A similar interaction between cardiovascular and
vascular remodeling also exists with disease, in which altered blood flow from heart
defects can incite maladaptive remodeling and plaque accumulation in
downstream arteries later in life.19 From our prior work and the work of others, it is
apparent that mechanical loading and 3D environment play a pivotal role in the
behavior of cells embedded within the vascular walls or on the surface of these
matrices, yet the molecular mechanisms, which regulate the mechanotransduction
pathways involved in the initiation and the progression of several types of
pathology, have yet to be determined20,29–32 Within the appropriate 3D physical
environment, these pathological conditions can be studied in an in vitro setting,
thereby elucidating novel mechanistic processes not previously substantiated with
conventional culture models.

5

Here, we report the design and fabrication of cellularized collagen tubular
constructs (cytotubes) that support representative vascular cells in an environment
capable of fostering dynamic stimuli and cellular adaptation. Experiments were
carried out to examine the effect of cellular tension on cells in these 3D collagen
gels. Contraction analysis showed these cylindrical cytotubes decreased in both
length and diameter when statically cultured without adding suture tension. Spatial
distribution of cells within cytotubes under cellular tension also remained more
uniform as compared to those under no external tension.
Collagen cytotubes containing different cell types, including FBs, bone
marrow primary cells (BMPCs), SMCs, and ECs, were analyzed for cell viability,
morphology, distribution, and structural contraction using static and dynamic
culturing techniques. Characterization of the cytotube cultures featured robust
growth and morphogenesis of vascular cells. The spatial distribution of cells within
collagen constructs changed as a function of time, with the exterior surface area
becoming increasingly occupied by f-actin. Analysis of cellularized collagen tube
contraction showed that constructs containing a combination of SMCs and ECs
contracted more than EC-only constructs, but less than SMC-only cytotubes,
indicating that heterotypic, cell–cell interactions play an important role during
histogenesis. These results support the premise that this collagen fabrication
technique is capable of producing cellularized constructs with multiple vascular cell
types and specific 3D geometries. The technique can also be used in combination
with our novel fluid flow bioreactor culturing system to further investigate the
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cellular, molecular, and mechanical mechanisms of vascular development and
disease in a dynamic in vitro culturing system.
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CHAPTER 2
MATERIALS AND METHODS2
2.1 CYLINDRICAL AND VASCULAR STENOSIS CYTOTUBE FABRICATION
2.1.1 Collagen Isolation
As initially described in Yost et al (2004), bovine dermis was cut into 4´6
cm strips and frozen before processing. All superficial epidermis was removed
prior to washing the collagen with running water. The collagen was incubated
overnight at 4°C in 2% Ca(OH)2 per hide weight then mixed well and placed in a
tumbler. After another incubation period in 4°C, the collagen was washed under
running water and placed in a 1 M NaCl solution and put back in 4°C conditions.
The collagen was adjusted to a pH of 5 with a 1 M HCl solution then washed with
deionized water until the conductivity was at 100 µS/cm. The hides were then cut
in 1 in2 pieces and placed in cold 0.5 M acetic acid solution. Pepsin was added at
a 50:1 hide weight to pepsin ratio followed by incubation at 4°C overnight. The
collagen was ground in a clean meat grinder with ice then mixed with 0.5 M acetic
acid solution and pH-adjusted to between 3.0 and 4.5 using 1 M HCl solution. After
incubating overnight at 4°C again, the pH was adjusted to 3.0 and added to a clean
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press. Cold 0.5 M acetic acid was mixed in with the pressed collagen. A solution
of 1 M NaCl was added to the liquid until the collagen came out of the solution
followed by another overnight incubation at 4°C. The collagen was then spun down
at 5000 to 7000 rpm for 30 minutes to remove the water and pH-adjusted to 5.5
with 1 M NaOH. The collagen was put into dialysis tubing and then placed in cold
water in 4°C until the conductivity read 50 µS/cm. After processing, the collagen
concentration was adjusted to a dry weight/wet weigh concentration of 1.25-2.77%
by adding water and pH-adjusted to approximately 4.9 by adding 0.5 M HCl. The
collagen was sterilized with 1,200 rad γ-irradiation before being used to fabricate
the tube constructs.
2.1.2 Cell Culture and Cellular Suspension
For the cylindrical cytotubes, human primary aortic smooth muscle cells
obtained from ATCC (ATCC PCS-100-012) were cultured with the vascular smooth
muscle cell growth kit (ATCC PCS-100-042) containing the vascular cell basal
medium (ATCC PCS-100-030) with 5 ng/mL rh fibroblast growth factor (FGF)basic, rh insulin, rh epidermal growth factor (EGF), 50 µg/mL ascorbic acid, 10 mM
L-glutamine, 5% fetal bovine serum, 25 ng/mL amphotericin B, 10 units/mL
penicillin, 10 µg/mL streptomycin, and 33 µM phenol red. Cells were cultured at
37°C, 5% CO2 in 100 mm petri dishes. The growth medium was changed every
other day to replenish nutrients and remove waste.
A cell line, derived from primary cultures of adult rat heart FBs, was used
as a source of cardiovascular FBs for the initial characterization studies of the
vascular stenosis cytotubes. Rat BMPCs, derived from isolated bone marrow stem
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cells, were used to promote vasculogenesis within the cellularized collagen
constructs.33 These cells, along with rat aortic SMCs and ECs, were grown in
Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal bovine serum,
1% penicillin/streptomycin, and 0.1% amphotericin B at 37°C, 5% CO2 in 100 mm
petri dishes. The growth medium was also changed every other day to replenish
nutrients and remove waste.
To prepare the cellular suspension for seeding, confluent plates of cells
were trypsinized (0.05% trypsin/0.02% ethylenediaminetetraacetic acid (EDTA) for
human SMCs and 0.25% trypsin/0.1% ethylenediaminetetraacetic acid (EDTA) for
rat cell types), pelleted via centrifugation, and re-suspended in fresh growth
medium. The concentrations of the cellular suspensions were calculated using a
hemocytometer (Bright-LineTM, Sigma-Aldrich®, Horsham, PA, USA). Cytotubes
were made using approximately one half of a confluent 100 mm plate of cells to
account for variation in size among different cell types. Cylindrical cytotubes were
made using 3.0 ´ 106 SMCs per tube. For the vascular stenosis cytotubes using
rat cell types, average cell concentrations for cytotubes were 3.01 × 106 for FBs,
3.32 × 105 for SMCs, 4.1 × 106 for ECs, and 4.3 × 106 for BMPCs.
2.1.3 Cellularized Collagen Polymerization Technique
Since polymerization of collagen occurs in the pH range of 6.0–8.0, and the
optimum pH for cells is typically 7.4, polymerization of the collagen and the
subsequent shift in pH had to be achieved in a manner that did not compromise
cell viability.34,35 HEPES (4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid)
buffer (10 mM HEPES, 0.14 M NaCl, 4.7 mM KCl, 1.3 mM MgSO4, 1.6 mM CaCl2),
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a widely used supplement in DMEM or other growth medium to maintain
physiological pH values, was chosen as the reagent to polymerize the solubilized
collagen gel while raising the final pH to 7.4. To find the most suitable alkalinity of
the neutralizing reagent, a range of 10× HEPES buffers, with different pH values
from 7.4 to 8.1 in 0.1 increments, were added to solubilized collagen at an 8:1:1
volumetric ratio (1.2 mL solubilized collagen: 150 μL 10´ HEPES: 150 μL cell
suspension for cylindrical cytotubes and 1.0 mL solubilized collagen: 125 µL 10´
HEPES: 125 µL cell suspension for vascular stenosis cytotubes). The pH values
of the collagen mixtures were measured again after mixing thoroughly to determine
which HEPES buffer solution produced the final desired collagen pH of 7.4.
Prior to polymerization, the collagen was slightly acidic with pH values
ranging from ~5.12 to 6.64 due to variation between batches of collagen. To
compensate for the fluctuations, a lookup table was created to determine the
alkalinity of 10× HEPES buffer necessary to obtain the final pH value of 7.4. Figure
2.1 depicts examples for collagen solutions with pH of 5.27, 5.95, and 6.64, which
would require 10× HEPES buffers of pH 7.84, 7.70, and 7.55, respectively, to
produce a final pH of 7.4.
From this empirical data, an equation (equation 2.1) was created to
determine the appropriate pH of the 10´ HEPES buffer to combine with the acidic
pH of the collagen in order to achieve the desired final pH of 7.4. In this equation,
“x” represents the value of the initial pH of the solubilized collagen, and “y”
represents the pH of the 10´ HEPES buffer that is needed to have an end pH of
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7.4 after mixing the collagen containing the cell suspension and the HEPES buffer
together.
𝑦 = −0.21169𝑥 + 8.9569

Equation 2.1

2.1.4 Casting Molds
For the cylindrical tubes, the lumen of the collagen tube construct was
created using stainless steel rods that were engineered as a simple straight,
cylinder as seen in Figure 2.2. For the vascular stenosis cytotubes, the lumen of
the collagen tube construct was created using stainless steel rods that were
micromilled with a pin and socket connection, which, when joined together, formed
an axisymmetric constriction in the center of the tubular mold. The pin and socket
apparatus allowed for the casting of the stenotic region of the tube lumen, in which
the diameter was reduced from 3.0 to 0.65 mm, while also facilitating the removal
of the steel rods from the collagen construct without disrupting the integrity of the
cellularized material (Figs. 2.3 a, b). The 8:1:1 ratio mixture of the collagen, 10×
HEPES buffer, and cell suspension was used as the casting material for the tube.
A collagen concentration of at least 1.0% was found to be necessary to maintain
construct integrity during the casting process. Collagen tubes with concentrations
<1.0% did not retain the shape of the mold, as shown in Figure 2.3c with tubes
made from 0.67% collagen. Increasing the collagen concentration improved
structural integrity (Figs. 2.3 d, e) until the collagen became too viscous to syringe
into the molds.
Dialysis tubing specialized for high permeability (Spectra/Por® 2, MWCO
12–14 kDa, Spectrum) was used as the exterior sheath or outer casing to aid in
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osmotic pressure optimization and rapid small molecule exchange, while retaining
the collagen molecules within the dialysis tubing. Dialysis tubing of 10mm flat width
was cut into pieces measuring 5 cm in length. Prior to tube assembly, the sheaths
were sterilized with 1,200 rad γ-irradiation and submerged in 10× HEPES buffer at
a pH of 7.4 to soften them.
2.1.5 Collagen Wall Fabrication
The cytotube constructs contained a range of cell type combinations located
within the collagen gel wall, in the tube lumen, or in both the wall and the lumen.
For the human SMCs, the straight cylindrical collagen tubes contained only SMCs
within the collagen wall. For the rat cell types, the following cell type combinations
were used in cytotube fabrication: FB-only (wall), FB-BMPC (wall), SMC-only
(wall), EC-only (lumen), and SMC-EC (wall and lumen). FB-only, SMC- only, EConly, and SMC-EC co-cultured cytotubes were used in static dish cultures while
the FB-BMPC cytotubes were used in the static and dynamic bioreactor cultures
as described in the Static and Dynamic Culturing section. Cellular seeding of the
collagen wall and casting of the collagen tube were done simultaneously. The
luminal seeding for EC-only and SMC-EC co-cultured cytotubes was performed
after fabrication of the collagen wall and is described in more detail in the next
section.
To make the cellularized collagen mixture, 1-1.2 mL of the collagen gel was
loaded into a 1.5mL microcentrifuge tube using a syringe and then mixed with 125150 μL filter-sterilized 10× HEPES buffer; 125-150 μL of the desired cell type
suspension was then added to the neutralized collagen gel and mixed thoroughly.
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Collagen tubes for vascular stenosis that did not contain cells within the wall were
formed using only collagen with 125 μL of 1× HEPES buffer at a pH of 7.4, which
was added to the collagen mixture in lieu of the cell suspension, in addition to the
125 μL of 10× HEPES buffer in order to maintain a consistent collagen
concentration for cytotubes with different cell combinations.
Microcentrifuge tubes containing either type of collagen mixture (cellular or
acellular) were centrifuged for ~10 s to remove air bubbles within the gel. The
mixture was slowly syringed into the mold with one end capped to avoid bubble
formation, which would compromise the integrity and uniformity of the construct.
Once filled, a cap was placed at the other end of the tube, before submerging the
entire mold in a sterile plastic culture tube (17 × 125 mm, FisherbrandTM,
Pittsburgh, PA, USA) containing cell media. Each mold was incubated at 37°C, 5%
CO2 in the plastic culture tube in the media for 24 h to allow for collagen
polymerization (Fig. 2.4a).
2.1.6 Vascular Stenosis Cytotube Luminal Seeding
Following collagen wall polymerization, the dialysis tubing and internal mold
rods were gently removed from the cytotubes. Collagen tubes containing ECs
within the lumen were seeded by pipetting 100 μL of cell suspension into the lumen
at each end of the construct. Afterwards, the luminally seeded cytotubes were
placed in sealed culture tubes containing media and affixed to a tube rotator (099A
RD5512; Glas-Col®, Terre Haute, IN, USA) that revolved at 17 rpm at 37°C, 5%
CO2 for 24 h (Fig. 2.4b). The cytotubes were positioned horizontally so that the
axial direction of the tubes was parallel to the rotational axis of the rotator, which
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allowed for even seeding of cells on the lumen of the construct. The co-cultured
cytotubes with SMCs within the wall and ECs in the lumen were synthesized by
making the cellularized collagen wall first and subsequently seeding the lumen with
ECs using the rotator-assisted seeding technique.
2.1.7 Static and Dynamic Culturing
After fabrication of the cytotubes, each construct selected for static dish
culture was transferred into a 60 mm petri dish and cultured in growth medium at
37°C, 5% CO2 (Fig. 2.4c). The cytotubes were maintained in static dish culture for
periods ranging from 24 h to 7 days with the culture media being changed every
48 h.
A custom-designed fluid flow bioreactor (Adams & Chittenden Scientific
Glass®, Berkeley, CA, USA) was used in addition to static culturing in petri dishes.
The cylindrical cytotubes containing only human SMCs within the collagen wall
were mounted in the bioreactors using sutures to examine the effect of sutures on
the cytotubes as compared to the non-sutured cytotubes that were examined in
static petri dish culture.
To determine the effects of flow on cells within the wall of the stenotic tubes,
cytotubes containing FBs and BMPCs within the tube wall were examined using
static and dynamic culture in the fluid flow bioreactor. The FB-BMPC combination
was used instead of FB-only cytotubes to evaluate the ability of the BMPCs to
promote vasculogenesis under the condition of applied flow as compared with no
flow. For both static and dynamic bioreactor culturing, the FB-BMPC cytotubes
were sutured onto the bioreactor as depicted in Figure 2.4d.29,30 Static bioreactor

15

culturing referred to constructs in bioreactors, which were not attached to any
pumps, whereas tubes selected for dynamic culturing were sutured in bioreactors
attached to pumps to receive applied flow. Cytotubes in dynamic bioreactor
cultures received an average volumetric flow rate of 3.33 × 10−9 m3/s. The flow
rate, which is lower than typical stenotic conditions for arteries of this scale, was
chosen to minimize pressure on the cytotube wall so that any changes in cell
morphology could be directly attributed to flow rather than flow and pressure
collectively. Furthermore, continuous flow was used to provide steady-state flow
conditions in order to minimize ambiguities encountered when analyzing the
results. Cytotubes of both culture types were removed from the bioreactors after
48 h of culture and processed for microscopy.
2.2 CONTRACTION ANALYSIS AND IMAGING
2.2.1 Contraction Measurement and Statistical Analysis
During the static culturing phases, the cylindrical cytotubes with human
SMCs were imaged after 0, 1, 3, and 7 days of static culture. The SMC-only, EConly, and SMC-EC co-cultured stenotic cytotubes were imaged daily to examine
the effects of the characteristic vascular cells on the collagen construct. The
dimensional changes in the tube diameter and length over a 7 or 10-day time
period were measured using NIH ImageJ software. Data were reported as means
with at least three independent experiments per treatment, and error bars
represent standard error of the mean. Statistical significance for the human SMConly cytotubes was determined using a one-way analysis of variance (ANOVA)
with repeated measures while the stenotic cytotubes were analyzed via a two-way
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ANOVA. Both sets of cytotubes underwent Tukey’s multiple comparisons test with
α values of 0.05. Differences between the group means were considered
significant at p < 0.05.
2.2.2 Confocal Microscopy Sample Preparation and Imaging
After culture to specific time points, cytotubes were fixed in 4%
paraformaldehyde/phosphate buffered saline (PBS) at 4°C for at least 24 h.
Cylindrical cytotubes were processed and embedded in paraffin before
being sectioned at thicknesses of 6-8 µm with a microtome. Slides were deparaffinized in xylene and rehydrated in decreasing concentrations of ethanol
before staining. Cytotubes for vascular stenosis were embedded in 5%
agarose/PBS gel and sectioned longitudinally using a vibratome at thicknesses of
150–200 μm. The sections were permeabilized with 0.1-0.25% Triton X-100/PBS
for 20min and washed with PBS three times, followed by blocking in 2% bovine
serum albumin (BSA)/PBS for 1 h at room temperature.
Immunofluorescent labeling was used to identify cell phenotypes.
Regardless of cell type, vascular stenosis cytotube sections were stained with
fluorescently labeled phalloidin (F-actin stain, Alexa Fluor 488®, no. A12379; Life
TechnologiesTM, Carlsbad, CA, USA), 4′6-diamidino-2-phenylindole (DAPI,
nuclear stain, no. D21490; InvitrogenTM, Carlsbad, CA, USA), and Cy3-labeled α
smooth muscle actin (Cy3-αSMA, no. C6198; Sigma-Aldrich®) overnight at 4°C.
Cylindrical cytotube sections were stained with phalloidin and DAPI as well. The
sections were washed three times with PBS for 10 min each, then mounted on
glass slides with 1,4-diazabicyclo[2.2.2]octane (DABCO, no. D2522; Sigma-
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Aldrich®). The cylindrical cytotubes were imaged with confocal imaging (Zeiss LSM
510 Meta; Carl Zeiss, Thornwood, NY, USA) and with the Invitrogen EVOS FL
Auto Cell Imaging System (Carlsbad, CA, USA). Vascular stenosis cytotube
sections were only imaged with confocal microscopy.
Confocal image stacks for vascular stenosis sections were collected in the
X, Y, and Z dimensions from 200 μm thick vibratome sections. Individual image
stacks were first collapsed in the Z dimension to a single projection resulting in
images that were 450 × 450 μm. These were then tiled using Photoshop (Adobe®,
San Jose, CA, USA) into transverse strips across the constriction nozzle regions,
enabling the visualization of intact vibratome sections in a single image.
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Figure 2.1 A lookup table for collagen polymerization was developed because the
desired final pH of 7.4 for the collagen mixture before adding the cell suspension
required estimating the appropriate pH value of 10× HEPES buffer in order to
neutralize the collagen, which was initially acidic but varied in pH value between
batches. The pH of the neutralizing buffer can be found at the intersection of where
the line for initial collagen acidity passes through the horizontal dashed line
representing a final pH of 7.4. Examples are shown for initial collagen pHs of 5.27,
5.95, and 6.64, which, respectively, require 10× HEPES buffers of pH 7.84, 7.70,
and 7.55 to produce a final pH of 7.4 before adding the cell suspension. Values
were determined via interpolation of the three standard curves shown.
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Figure 2.2 The stainless steel mold engineered with interlocking socket ends to
mold the lumen of the cylindrical cytotubes. The design allows for the removal of
the stainless steel mold while maintaining the collagen construct after it has
polymerized.
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Figure 2.3 A schematic of the collagen construct cast using the stenotic vessel
design (a) shows the axisymmetric stenotic region in the tube lumen where the
diameter is reduced from 3.0 to 0.65mm. Stainless steel rods with interlocking pins
and sockets formed the dimensions of the inner lumen and stenotic region of the
collagen tubes (b). Cytotube constructs made with 0.67% (c), 1.0% (d), and 1.8%
(e) collagen type I, respectively, show that a collagen concentration of 1.0% or
more was necessary for the cytotubes to maintain the shape of the mold.
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Figure 2.4 Collagen tubes containing cells within the wall and in the lumen were
fabricated via a two-step process in which the cells within the wall were produced
via casting, and then the lumen was seeded with cells. Cytotube constructs that
have been cast around the stainless steel mold and dialysis tubing were placed in
culture tubes for 24 h to allow for collagen polymerization (a). Luminally seeded
cytotubes were placed on the rotator-assisted luminal cell seeding apparatus
inside a tissue culture incubator for 24 h (b). Cytotube constructs could be cultured
in petri dishes (c) or mounted within the bioreactors for culturing (d).
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CHAPTER 3
RESULTS3
3.1 CYLINDRICAL CYTOTUBE RESULTS
3.1.1 Comparison of Sutured and Non-Sutured Cylindrical Cytotubes
Cytotubes containing only human SMCs within the collagen gel wall were
cultured in bioreactors with sutures holding the tubes in place and compared to
those

cultured

in

petri

dishes

without

sutures

(contraction

tubes).

Immunofluorescence staining with DAPI to visualize the cell nuclei allowed for the
depiction of cell distribution within the cytotubes after 1, 3, and 7 days of their
respective culture conditions. As illustrated in figure 3.1, there were very few
differences between the cytotubes cultured with and without sutures. After three
days of culture, the cells that had been sutured were shown to have a more even
cellular distribution throughout the length of the collagen tube as compared to the
cytotube that had been cultured statically in a petri dish, which showed a lack of
cellularization in the middle of the tube (Figure 3.2). This trend continued as
depicted in day 7 of culture (Figure 3.3) where cells in the contraction tube

3
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appeared to be clustered towards one end of the collagen tube rather than the
middle or the other end of the tube as indicated by the blue staining for DAPI.
3.1.2 Contraction of Cylindrical Cytotubes
The cylindrical cytotube constructs containing only SMCs were
observed to contract over time in length and diameter while in static dish culture
for seven days (Fig. 3.4). The contractile behavior of cells was most pronounced
in cytotubes in length rather than diameter. The differences in mean length
contraction amounts were significant between Day 1 and Day 3 and Day 1 and
Day 7 with no significant differences for between Day 3 and Day 7 for p-values of
p < 0.05. The tube length at Day 1 was 94.28 ± 1.05% of the original tube length
at Day 0. Interestingly, the greatest amount of contraction in length occurred
between Days 0 and 1, with a reduction of 5.75% while Day 1 to Day 3 saw a
reduction of 5.26% to yield 88.98 ± 0.91% of the Day 0 tube length. Day 3 to Day
7 saw the smallest contraction amount to produce a length that was 88.12 ± 0.82%
of the initial tube measurement.
Analysis of tube diameter contraction found that SMC-only cytotubes also
showed decreases in the outer diameter of the tube, however these decreases
were not as pronounced as the reduction in length. Mean differences of the
contraction diameter were significant between Day 1 and Day 3 as well as between
Day 1 and Day 7, however there was no significance in the outer diameter
reduction between Day 3 and Day 7 for p < 0.05. The greatest amount of
contraction, similar to the length data, occurred between Day 0 and Day 1 with a
3.79% decline in the original outer diameter values to yield 96.21 ± 0.84%. From
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Day 1 to Day 3, the tubes contracted 2.55% to 93.66 ± 0.71% of the initial outer
diameter. By Day 7, the tubes remained at 92.64 ±0.94% of the starting diameter.
3.2 VASCULAR STENOSIS RESULTS
3.2.1 Characterization of Stenotic Cellularized Constructs
3.2.1.1 FB-Only Cytotubes
Initially, cytotubes seeded with only FBs within the wall were used to verify
the viability of cells within the collagen constructs. Phenotypical changes
associated with time in culture for FBs growing within the collagen wall of the
scaffold are shown in Figure 3.5. On day 1 (Figs. 3.5a, 3.5b), the cells within the
collagen displayed a rounded, retracted shape typical of trypsinized cells. On day
2 of culture (Figs. 3.5c, 3.5d), the FBs within the collagen matrix exhibited a
morphology that was more stellate in shape, which is typical of mesenchymal cells.
Days 3 and 4 of culture showed cells within the wall with more exaggerated stellate
morphologies (Figs. 3.5e, 3.5g), whereas cells near the luminal surface of the
constructs aligned along the edges of the wall and showed increased expression
of f-actin based on staining intensity (Figs. 3.5f, 3.5h). By day 5, the FBs were
more densely associated within the wall (Fig. 3.5i) and at the luminal surface with
visible assembled layers of flattened, squamous cells (Fig. 3.5j) with intracellular
actin stress fibers (Fig. 3.5j, top arrow) and organized αSMA filaments (Fig. 3.5j,
bottom arrow). After 1 week, cells within the collagen matrix of the tube wall were
overall more mesenchymal in morphology (Fig. 3.5k), whereas a cross-sectional
view of the construct showed an epithelial-like organization of cells on the luminal
surface of the cytotube (Fig. 3.5l). The increasing cellular alignment and f-actin
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network organization over time can be observed by comparing the fenestrated
layer in day 3 with the more confluent layers in days 4 and 6 (Figs. 3.5f, 3.5h, 3.5l).
3.2.1.2 EC-Only Cytotubes
Rat aortic ECs were seeded onto the lumen of cytotubes using the rotational
seeding method as described earlier. On day 1, after 24 h of rotational culture,
globular clusters of polygonal cells with dense f-actin networks were found on the
luminal side of the cytotube (Figs. 3.6a, 3.6b). On day 2, the globular clusters of
ECs were elongated along the wall edge (Fig. 3.6c); however, other cell clusters
displayed cortical actin filaments aligned with adjacent cells along the luminal
boundary, implying the formation of cell–cell junctions, an important characteristic
of endothelial barrier function (Fig. 3.6d). Increasingly confluent areas of
squamous endothelium were observed on the luminal surface of the cytotubes at
day 5 and 7 of static culture (Figs. 3.6e–h). An additional feature of note is the
expression of αSMA by some of the ECs in several of the time points shown in
Figure 3.6. While αSMA is traditionally considered to be a marker of SMCs, it has
also been found in some ECs in the luminal surface of the human, rat, and mouse
thoracic aorta and in ECs undergoing endothelial-to-mesenchymal transition
(EndMT).36 EndMT is the process by which ECs acquire mesenchymal markers
such as αSMA and neural–cadherin and gain migratory and invasive capacities
while losing cell–cell junctions and EC markers such as CD31 and vascular–
endothelial–cadherin. EndMT is essential for arterial development and tissue
regeneration but also plays a role in tissue fibrosis and other pathological
processes including atherosclerosis.37 Although the exact reason for the αSMA
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expression here is unknown, it can be said that the ECs in the cytotube exhibited
more than one phenotype.
3.2.1.3 SMC-Only Cytotubes
Collagen cytotubes containing only SMCs within the wall and no cells in the
lumen were cast using the techniques mentioned above. Figure 3.7 shows images
from vibratome sections of the SMC-only cytotubes that were assembled by tiling
transverse sections from the exterior wall up to the constriction nozzle region.
Representative cytotube cultures are shown for days 1, 3, 5, and 7. On day 1,
SMCs within the collagen were rounded, as was observed for the same time point
for the FB cultures in Figure 3.5. Initially, SMCs were dispersed throughout the
collagen matrix of the construct. At days 3, 5, and 7, SMCs transitioned in shape
and location from uniformly spherical to spindle-like on the luminal side and stellate
near the outer wall. In addition, an increasingly confluent layer of aligned SMCs
formed along the longitudinal direction of the cytotube while fewer cells remained
near the luminal wall (Fig. 3.7).
3.2.2 Contraction of EC, SMC, and SMC-EC Co-Cultured Cytotubes
The cytotube constructs containing characteristic vascular cells were
observed to contract over time in length and diameter while in static dish culture.
The contraction of SMC-only, EC-only, and SMC-EC co-cultured cytotubes was
examined over a 10-day culture period (Fig. 3.8). The contractile behavior of cells
was most pronounced in cytotubes seeded with only SMCs (Fig. 3.8a). EC-only
cytotubes exhibited the smallest contraction amount in length (8.34 ± 2.1%) as
compared with the other two groups, whereas both SMC-only and SMC-EC co-
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cultured cytotubes showed much greater reductions in length (Fig. 3.8b). While
SMC-only cytotubes became on average 58.95 ± 1.6% shorter in length after 10
days of static culture, the SMC-EC co-cultured cytotubes decreased only 29.95 ±
2.4% in length during that same time period, suggesting that the presence of ECs
limited the ability of the SMCs to contract or adapt the construct. The differences
in mean length contraction amounts were significant for all culture types at days 6
and 10 with no significant differences for any culture type at day 2 for p-values of
p < 0.05.
Analysis of tube diameter contraction found that, interestingly, SMC-only
and SMC-EC cytotubes showed increases from the original tube outer diameter at
day 2, which could have been indicative of a compensatory mechanism for the
initial decreases in length or early SMC expansion and adaptation of the tube wall
(Fig. 3.8c). Consistent with the pattern of length contraction, the greatest decrease
in diameter occurred in SMC-only cytotubes with 56.81 ± 1.5% followed by SMCEC cytotubes with 24.45 ± 2.5% and EC-only cytotubes with 11.05 ± 4.7%. Mean
differences of the contraction diameter were only significant at day 10 for SMC
versus SMC-EC and SMC versus EC for p < 0.05.
3.2.3 Dynamic Culturing of Cytotubes with FBs and BMPCs
After cytotubes with characteristic vascular cells in static dish culture
demonstrated robust growth and morphogenesis for FBs, SMCs, and Ecs, we
sought to examine the effect of flow with vasculogenesis via static and dynamic
bioreactor cultures, using our previously-described custom fluid flow bioreactor
system.29,30 For initial characterization of the bioreactor-cultured tubes, we chose
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to use co-cultures of FBs and BMPCs cast within the wall in order to examine
whether the BMPCs would differentiate in cytotubes cultured under flow compared
with no- flow cultures. The FB-BMPC cytotubes selected for dynamic culturing
were mounted in the bioreactors, which were attached to pumps that applied
steady-state flow at an average volumetric flow rate of 3.33×10−9 m3/s for 48h. Noflow controls were mounted onto bioreactors that were not connected to pumps
and cultured for 48h. As depicted in Figure 3.9, cells in the cytotubes cultured with
flow aligned along the edges of the collagen construct, whereas cytotubes that
were not subjected to flow showed cells distributed across the entire width of the
wall. In addition, constructs with flow exhibited αSMA that was more aligned and
organized along the edge of the collagen wall despite the presence of more
pronounced αSMA in control samples (Fig. 3.9). Cytotubes cultured with flow also
showed more interconnected networks of cells. In general, only a few differences
were observed between the flow and no-flow cytotube constructs cultured in
bioreactors and could be due to the low flow rate, the absence of applied pressure,
or lack of pulsatile flow. Cells in both the flow and no-flow groups were similar to
the static cultured FB constructs in Figure 3.5 in their morphology and in the
expression pattern of αSMA.
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Figure 3.1 SMCs seeded within the collagen wall of cytotubes cultured without
sutures in static petri dishes showed very few differences in cellular distribution as
depicted by DAPI staining intensity (blue staining, cell nuclei) compared to SMCs
in cytotubes that were sutured in bioreactors.
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Figure 3.2 Cytotubes sutured within bioreactors displayed more even cellular
distribution as indicated by the cell nuclei (DAPI) on day 3 than those that were
subjected to static petri dish cultures. The day 3 contraction tube showed fewer
cells in the middle region of the tube, but more cells were clustered near the ends
of the tube as indicated by relative blue staining intensity.
31

Figure 3.3 According to relative blue staining intensity, SMCs in day 7 cytotubes
that were cultured under static petri dish cultures without sutures were gathered
more on one end of the tube whereas the SMCs that were cultured with sutures in
bioreactors still maintain very even cellular distribution throughout the entire tube
geometry.
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Figure 3.4 Cytotube length and diameter contraction varied over time. The
analyses of tube contraction for length (top) and outer diameter (bottom),
respectively, were plotted as mean ± SEM. SMC-only cytotubes cultured without
sutures in petri dishes showed a high level of shrinkage for length, measuring at
88.12 ± 0.82% of the original tube length and 92.64 ± 0.94% of the original tube
diameter after seven days of culture. For p<0.05, mean differences of contraction
were found to be significant between Day 1 and 3 and Day 1 and 7 for both tube
length and diameter (as indicated by the asterisks).

33

Figure 3.5 Fibroblasts (FBs) cast within the cytotube wall were initially spherical in
shape throughout the entire construct (a,b) but over time adopted different
morphologies specific to their location within the cytotube. FBs within the wall
exhibited early (c,d) and more exaggerated (e,g) stellate morphologies, typical of
mesenchymal cells, with densely associated layers of FBs in later time points (i,k).
In contrast, FBs near the luminal surface aligned along the wall edge with
increased f-actin expression based on green staining intensity (f,h) and flattened
squamous morphology in epithelial-like organization (j,l). Numerous intracellular
34

stress fibers (j, top arrow) and organized α smooth muscle actin filaments (red
staining, j, bottom arrow) were visible along with cell nuclei [4′6-diamidino-2phenylindole (DAPI), blue staining].
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Figure 3.6 Endothelial cells (ECs) were seeded onto the luminal surfaces of
cytotubes where small globular clusters of polygonal endothelial cells with
associated f-actin networks (green staining) were initially observed (a,b).
Extensive cortical arrangements of f-actin associated with adjacent ECs along the
luminal boundary indicated the potential development of tight junctions between
these cells (c,d). In later time points, some ECs had α smooth muscle actin
36

filaments (f, red staining) although most exhibited increasing confluency and
squamous morphology (e,g,h). Cell nuclei are shown with blue staining [4′6diamidino-2-phenylindole (DAPI)].
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Figure 3.7 Vibratome sections of smooth muscle cells (SMC)-only cytotubes were
stained for confocal microscopy, and the resulting images were collected and tiled
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together. Representative sections from days 1, 3, 5, and 7 are shown in the four
panels displayed from top to bottom that correspond to the exterior wall edge to
the luminal edge, respectively. The schematic at the top of each panel depicts the
geometry of the tube section and the area enclosed by the blue box represents the
area displayed in the panel. Initially, spherical cells are observed throughout the
construct. Fusiform SMCs can be seen on the luminal side in inter- mediate time
points while stellate SMCs accumulate at the exterior wall in later time points.
Green staining is f-actin, blue is 4′6-diamidino-2-phenylindole (DAPI), and red is α
smooth muscle actin.
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Figure 3.8 Cytotube length and diameter contraction varied with cell composition
as shown in representative images of cytotube contraction over time (a). The
analyses of tube contraction for length (b) and outer diameter (c), respectively,
were plotted as mean ± SEM. Smooth muscle cells (SMC)-only cytotubes showed
the highest level of shrinkage for length (58.95 ± 1.6%) and diameter (56.81 ±
1.5%), followed by SMC-endothelial cells (EC) cytotubes with 29.95 ± 2.4% for
length and 24.45 ± 2.5% for diameter. EC-only cytotubes showed almost no
shrinkage in 10 days of static culture with decreases of 8.34 ± 2.1% in length and
11.05 ± 4.7% in diameter. For p<0.05, mean differences of contraction length were
found to be significant between all culture types for day 6 and 10, while mean
differences of contraction diameter were found to be significant only at day 10 for
SMC versus SMC-EC and SMC versus EC (as indicated by asterisks).
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Figure 3.9 Static and dynamic culturing of cytotubes was performed with fluid flow
bioreactors. The two left panels are representative images of cytotubes containing
fibroblasts (FBs) and bone marrow primary cells (BMPCs) that were attached to
bioreactors with no flow applied. The two panels on the right are representative
images of FB-BMPC cytotubes cultured on bioreactors connected to pumps with
an applied flow rate of 3.33 × 10-9 m3/s of culture media through the tube lumen.
Both types of cytotubes were cultured for 48 h. Cytotubes cultured with flow
showed increased alignment of cells and α smooth muscle actin (red staining)
compared with control samples. Green staining is f-actin and blue is 4′6-diamidino2-phenylindole (DAPI).
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CHAPTER 4
DISCUSSION AND CONCLUSIONS4
4.1 CYLINDRICAL CYTOTUBE DISCUSSION
4.1.1 Cylindrical Cytotube Discussion
We have previously developed numerous models of three-dimensional
in vitro systems using collagen as the principle material in order to simulate
biological processes.27,29,30,38,39 Very little is known about how cells reorganize and
align themselves in 3D environments where there are two extremes: vascular cells
under tension and cells that are free to restructure their environment at will without
the interference of outside sources.40,4142 Experiments were carried out to examine
the effect of cellular tension on vascular smooth muscle cells in these 3D collagen
gels by culturing cylindrical cytotubes in static petri dishes with no attachments and
in bioreactors mounted with sutures without applied flow.
Immunofluorescent staining proved to be challenging with these constructs,
however the reasons for this are still unknown and warrant further study. While it
is possible that paraffin-embedding could have created the barriers in staining, it
is unlikely given that DAPI proved to have viable staining results. Analysis of the
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EVOS images using DAPI to delineate cellular distribution illustrated differences in
cellular alignment within the sutured and non-sutured collagen tubes. Over seven
days of culture, cylindrical cytotubes that were sutured in bioreactors maintained
even cellular distribution as indicated by blue staining from DAPI for cellular nuclei.
After three days of culture, cells in non-sutured cytotubes showed more
cellularization at either end of the tube with fewer cells in the middle. This could
perhaps indicate that cells were migrating as a result of some stimuli or that they
were dying. Further analysis and staining for f-actin as well as other SMC markers
would provide more clarification. Following seven days of culture, cytotubes
without sutures had far more cellularization at one end of the tube than the other.
Again, this warrants more staining for a conclusive explanation as to the
phenomena, however it is very evident that cytotubes with sutures displayed even
cellular distribution in both Day 3 and Day 7 samples, suggesting that cellular
tension does play a role in cellular reorganization within type I collagen martrices.
Contraction analysis showed these cylindrical cytotubes decreased in both
length and diameter when statically cultured without tension added by sutures.
While contraction for both length and diameter were significant between Day 1 and
Day 3 and between Day 1 and Day 7, neither contraction amount was significant
between Day 3 and Day 7 for length or diameter. This result could suggest that by
Day 3, the majority of the cells have reorganized and restructured the 3D collagen
environment to their satisfaction; thus, there is no need for more contraction if the
SMCs are at optimal tension within the 3D matrix.12 This assertion would also
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necessitate further research and confirmation with staining for specific cell markers
and PCR.
4.2 VASCULAR STENOSIS DISCUSSION
4.2.1 Vascular Stenosis Discussion
Vascular stenosis can develop from numerous conditions or pathologies at
any stage of life and often provokes significant detrimental consequences to
cardiovascular health.5–7 Despite increasing prevalence and mortality due to
cardiovascular diseases associated with vascular stenosis, a sufficient artery
model that can be used to examine and define the mechanism in which these
pathologies occur has yet to be developed; hence, the roles that specific
molecules, cells, environments, and hemodynamic stimuli play in the events that
lead to the progression of these conditions are not clearly understood.20,21,31
The lack of complexity offered by standard two-dimensional cell cultures is
analogous to the convoluted results of in vivo studies that, due to natural variation
and the multifaceted system of responses in the body, cannot be conclusively
analyzed and interpreted. The paucity of adequate systems for the study of
vascular diseases and engineered tissues has elicited a strong demand for
intermediate levels of complexity in research models while also serving as a
motivation for these studies. A number of vascular biofabrication methodologies
have been developed prior to this investigation, however few have incorporated
cells into the vascular wall and in the lumen as seen in this study.22,43–49 Here, two
processes, cellularized collagen wall casting and rotator-assisted luminal cell
seeding, were developed to generate cellularized tubes or “cytotubes” with several
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different combinations of cells within the collagen wall and in the tube lumen. The
casting of the cellularized collagen wall required a protocol to be designed in which
the requisite pH shift for collagen polymerization was carried out while maintaining
cell viability. This polymerization technique allowed us to produce cellularized
collagen tubes serving as arterial scaffolds that can be cultured to allow
morphological adaptation under conditions of applied flow or static culture. From
this, we created a construct with a stenotic luminal geometry that, under dynamic
flow conditions, can be used to generate areas of disturbed flow while also
exposing cells in the lumen and the wall of the cytotube to mechanical stimuli from
the force of the applied flow.17 While future studies involving further manipulation
and analysis of the applied flow and its effects are required to achieve conditions
similar to the in vivo environment, our cytotubes coupled with the dynamic
bioreactor culture systems present a unique innovative method for gaining insight
into vascular pathology.
In general, the processes that regulate the transduction of mechanical
stimuli into cellular activities are not well characterized.50 In the case of arterial
stenosis, the narrowed lumen alters hemodynamics, including blood flow rate and
pressure, hence the overall mechanical environment of vascular cells is directly
affected.7,20 More specifically, the process by which this altered environment
impacts cellular processes such as endothelial activation, smooth muscle cell
proliferation, and pathological ECM remodeling is not clear.6,7,21 The signaling
between cells of the intima, media, and adventitia is likely, if not required, to be
coordinated during pathological progression, hence the presence of more than one
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representative vascular cell type in models of vascular disease is essential.20
Delineating these mechanisms offers the opportunity to intervene therapeutically
at a number of clinically relevant stages of disease progression, essentially from
prevention to regeneration.
To accommodate the presence of more than one vascular cell type in our
preliminary model of vascular stenosis, we developed our techniques for luminal
cell seeding in combination with the cellularized wall casting, which allowed for the
generation of cytotubes containing cells within the collagen wall and in the tube
lumen as seen with our SMC-EC co-culture cytotubes. To investigate the effects
of seeding cytotubes with different cell types, we compared SMC-only, EC-only,
and SMC-EC cytotubes in static culture and measured dimensional changes in
tube diameter and length over time. This study found that the SMC-EC cytotubes
behaved differently than either EC- or SMC-only constructs, taking on an
intermediate tube contraction phenotype in both length and diameter. Adding
complexity to this system offers the opportunity to determine the various roles of
interactions between resident vascular cells and the immune cells that are thought
to drive pathological remodeling of the vessel tissue.
One of the most notable phenomena observed with our system was the
increasingly uneven dispersion of SMCs within the tube wall and the increasing
cellularity of SMCs at and near the outer surfaces of the cytotube over time (Fig.
6). While this observation can also be considered a limitation of our system, future
studies are planned to investigate this as it is not clear whether cells within the wall
migrate toward the surfaces, die at higher rates between the surfaces, or whether
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surface-dwelling cells proliferate at higher rates. SMCs are reported to proliferate
in response to pressure51; thus, it would be interesting to carry out these studies
in a system of variable pressure in order to determine how this affects SMC density
and distribution. Though our initial flow experiments with cytotubes fabricated with
FBs and BMPCs revealed only a few prominent differences from no-flow cultures,
future experiments using different parameters will investigate this further. The
initial result is not surprising since flow is typically sensed by lumen-lined EC, which
were not present in that particular experiment; however, it is known that in the
event of EC denudation, adventitial FBs migrate and contribute to neointima
formation.20 In addition, it has been reported that minor increases in interstitial flow,
which is flow that permeates through the vascular wall and is much lower than the
flow levels typically sensed by ECs, can promote FB migration.20,52,53 Although
interstitial flow rates were not calculated in this study, it is possible that the increase
in cellular alignment along the wall edges, in cytotubes cultured with flow, could be
a result of the applied flow rate promoting FB motility. The lack of extensive distinct
characteristics in flow and no-flow tubes may also be attributed to the low, creeping
level of flow or the lack of applied pressure under which those samples were
cultured. This creeping flow rate was intentionally chosen because it resulted in
minimal pressure levels compared with conditions in vivo, which was an integral
step in discerning the effects of flow rather than pressure and flow combined on
the vascular environment. The normal complementary relationship between blood
flow rate and pressure is disrupted in vascular stenosis; hence these components
and their effects should be evaluated separately and together. Further
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experimentation is necessary to determine the extent of the influence from the
creeping flow and low pressure factors and if differences exist between the
proximal, stenotic, or distal sections of the cytotube.
4.3 CYLINDRICAL CYOTUBE AND VASCULAR STENOSIS CONCLUSIONS
Using a unique fabrication approach that allows for polymerization of
collagen while maintaining cell viability, we have created and cultured cellularized
tubes with cylindrical geometry and stenotic luminal geometry that support the
growth and morphogenesis of resident vascular cell types. Furthermore, these
stenotic constructs were coupled with a fluid flow bioreactor to investigate the
effects of low, creeping flow through the tube lumen. Future investigations
involving cytotubes cultured in bioreactors can provide more insight into the
hemodynamic forces and interactions with the tissue that drive developmental and
pathological processes. Imminent endeavors for this research include: co-culturing
cytotubes with more than two cell types; varying the flow properties and
hemodynamic stimuli for bioreactor cultures and developing cytotubes with
different geometries to generate disturbed flow. Co-culturing the three
characteristic vascular cell types together, ECs, SMCs, and FBs, could potentially
produce dramatically different results with regards to cellular position and
dispersion, ECM development, and other organizational trends. Altering the
geometries of the cytotubes would also help to define specific cellular responses
to disturbed flow in a region-specific manner. Lastly, further use of the bioreactors
for culturing tubes under steady flow or conditions more similar to the in vivo
environment can help to delineate some of the cellular responses to specific
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mechanical stimuli. Our novel fabrication processes with the versatile culturing
system offer a substantial approach with extensive potential to make a contribution
to the field of research for vascular disease and tissue engineering.
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APPENDIX A
CONOTRUNCAL HEART DEFECTS: ALTERED TISSUE
MORPHOLOGY AND HEMODYNAMICS5
Each year in the US, about 40,000 babies are born with congenital heart
defects (CHDs).54 While the array of causes of CHDs continues to widen and
diversify, the prevalence of CHDs, especially the more common, less severe
CHDs, is growing.55 CHDs are known to be caused by genetic mutations and
irregular hemodynamic forces during embryonic development; however, the cause
of specific types of CHDs relative to these factors is much more obscure as many
known aberrations in heart development produce a variable range of CHDs.
Furthermore, the extent of the interaction between genetic and environmental
components is an even more nebulous area of research.56 To elucidate more
information on the interplay between molecular and hemodynamic influences, we
have utilized two different models of CHDs to analyze tissue morphology and
create

three-dimensional

reconstructions

of

CHDs

in

order

to

predict

hemodynamic properties. An avian model of Tetralogy of Fallot (TOF),
characterized by ventricular septal defect, pulmonary obstruction (stenosis or

5

Parts of this appendix were excerpted from the following research abstract:
1. Jones RS, Junor L, Hutson MR, Kirby ML, Goodwin RL. Conotruncal
Heart Defects: Altered Tissue Morphology and Hemodynamics. Microsc
Microanal. 2017;23(S1):1174-1175. doi:10.1017/S1431927617006535
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atresia), overriding aorta, and right ventricular hypertrophy, has been developed
through inhibition of Sonic hedgehog (Shh), which reduces proliferation of the
secondary heart field (SHF). The Shh-null mouse was originally described as a
phenotypic equivalent of TOF with pulmonary atresia as Shh is necessary for
outflow tract (OFT), neural crest (NC) cell, and SHF proliferation. In previous
studies, cyclopamine, an inhibitor of hedgehog signaling, decreased SHF
proliferation and migration. Abnormal SHF proliferation has been linked to arterial
pole defects, suggesting that cyclopamine treatment may yield arterial pole defects
later in development.57 Ablation of the NC has also been used as another avian
model of CHDs that most commonly results in persistent truncus arteriosus (PTA)
or other OFT malalignment defects such as double outlet right ventricle and TOF.
NC ablation results in a failure of the SHF to contribute myocardium, which yields
disrupted patterning of the arterial pole.57
A.1 MATERIALS AND METHODS
Stock cyclopamine was dissolved in 95% EtOH and diluted with PBS.57,58
In the present study, cyclopamine-treated eggs were windowed at Hamburger
Hamilton (HH) stage 14 to pipette 10 µL of cyclopamine (0.8 µg/µL) or PBS/EtOH
(control) onto the embryo, then resealed with tape and incubated. Cyclopamine
treatment at HH 14 coincides with the initial contribution of myocardium to the distal
OFT by the SHF.57 For neural crest-ablated eggs, a pulsed nitrogen/dye laser
(VSL-377/DLM-110; Laser Science Inc., Newton, Massachusetts, USA) was used
to ablate the NC cells from the midotic placode to the third somite of HH stage 8
chicken embryos.59 These cells seed the 3rd, 4th, and 6th pharyngeal arches and
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have been defined as the cardiac NC. For neural crest ablated embryos, eggs were
windowed after 30 hours of incubation then the embryos were lightly stained with
neutral red–impregnated agar and staged. At HH 42, eggs of both treatment types
were harvested, and the hearts and outflow vessels were fixed in either
paraformaldehyde or glutaraldehyde then paraffin-embedded, sectioned (8 µm),
and stained. H&E staining and Movat’s pentachrome were used to analyze overall
morphology (figure A.2), and staining with aSMA, collagen type I, tenascin, elastin,
and DAPI was used for confocal microscopy.
Immunofluorescent labeling was used to identify cell phenotypes. All
sections for confocal imaging were stained with fluorescently labeled 4′6diamidino-2-phenylindole (DAPI, nuclear stain, no. D21490; Life Technologies,
Carlsbad, CA, USA). One set of sections was stained with a rabbit anti-chicken
collagen type I primary antibody (no. AB752P; EMD Millipore, Temecula, CA,
USA), a goat anti-rabbit Alexa Fluor 488 secondary antibody (no. A11008; Life
Technologies, Carlsbad, CA, USA), and an alpha smooth muscle actin (aSMA)
antibody conjugated with Cy3 (no. C6198; Sigma-Aldrich, St. Louis, MO, USA). A
second set of sections was stained with a rabbit anti-chicken tenascin primary
antibody (no. AB19013; EMD Millipore, Temecula, CA, USA), a goat anti-rabbit
Alexa Fluor 488 secondary antibody (no. A11008; Life Technologies, Carlsbad,
CA, USA), and an alpha smooth muscle actin (aSMA) antibody conjugated with
Cy3 (no. C6198; Sigma-Aldrich, St. Louis, MO, USA). A third set was stained with
a rabbit polyclonal elastin primary antibody (no. AB21610; Abcam, Cambridge,
MA, USA), a goat anti-rabbit Alexa Fluor 488 secondary antibody (no. A11008; Life
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Technologies, Carlsbad, CA, USA), a mouse anti-chicken MF20 primary antibody
(Developmental Studies Hybridoma Bank, Iowa City, IA, USA), and a donkey antimouse Alexa Fluor 546 secondary antibody (no. A10036; Life Technologies,
Carlsbad, CA, USA). The sections were mounted on glass slides with 1,4diazabicyclo[2.2.2]octane (DABCO, no. D2522; Sigma Aldrich, St. Louis, MO,
USA) for confocal microscopy imaging (Zeiss LSM 510 Meta; Carl Zeiss,
Thornwood, NY, USA).
AMIRA software was used to generate 3D models of myocardial and vessel
tissue in addition to flow space from tiled serial sections of the heart and associated
vessels.
A.2 RESULTS
At HH 42, the control, cyclopamine, and neural crest ablated (NCA) hearts
were harvested from the chick embryos. Prior to harvesting, images were taken of
the hearts to initially assess the overall structure of the hearts (Fig. A.1). Upon
inspection, wide variations in outflow tract (OFT) vessel patterning were present in
the cyclopamine and control hearts as compared to controls. In the normal chick
hearts, the left and right brachiocephalic trunks and the aorta were shown to be
originating from the left ventricle while the pulmonary trunks originated from the
right ventricle (Fig. A.1 a-c). In Figure A.1 d, the pulmonary trunk was not visible,
which would indicate complete pulmonary atresia, and there appeared to be an
extra vessel originating from the aortic OFT. The cyclopamine heart in parts e and
f also showed deviations in vessel patterning as compared to the control hearts.
The NCA hearts in parts A.1g through A.1i possessed even more abnormal vessel
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patterns, most of which indicated persistent truncus arteriosus, which is
characterized by a common OFT.
In order to understand the vessel arrangement within the HH 42 hearts, the
sectioned hearts were stained with Movat’s pentachrome. Red staining indicates
muscle, blue staining for ground substance and mucin, yellow for collagen fibers,
and dark purple to black for nuclei and elastic fibers. In figure A.2, The control
hearts in parts a and d had a well-defined aorticopulmonary septum (APS), which
separates the aortic and pulmonary arteries. The APS of the cyclopamine heart in
part e was very thin in comparison to that of the control hearts, while the other
cyclopamine heart in part b and the NCA hearts in parts d through f lacked an APS
entirely. In addition, the cyclopamine hearts had more ground substance based on
blue staining intensity around the aorta and pulmonary vessels, which could
indicate even more of an altered functionality in the muscle itself. The cyclopamine
heart in part b was much smaller in overall size with what appeared to be a
common outflow tract (OFT), however this was in fact complete pulmonary atresia,
not PTA. The cyclopamine heart in part e also appeared to have a different shape
compared to the control hearts as it was wider but more compact. The NCA hearts
(c, f) demonstrated PTA and approximately four and a half leaflets in the main
vessel of each heart. The NCA hearts were both noticeably smaller than the control
hearts.
Confocal imaging was performed for the aortic and pulmonary vessels of
the control and cyclopamine hearts as well as the common OFT of the NCA hearts.
In Figure A.3, staining was done to show DAPI for cell nuclei and red for aSMA for
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parts a through j. Parts a through e have green staining for collagen type I while
parts f through j have green staining for tenascin, which is an ECM protein made
by migrating cells like the neural crest during development.60 The control aortas
(a, f) showed a more uniform shape of the leaflets with smaller sinuses than in
cyclopamine aortas. The cyclopamine aortas had more collagen type I overall (b)
and aSMA (b, g) as indicated by their respective relative green and red staining
intensities. The pulmonary vessels in the control hearts also had more collagen
type I (c) and tenascin staining (h) in the valve leaflets than those in the
cyclopamine hearts (d, j) based on relative staining intensity. The valve leaflets of
the common OFTs in the NCA hearts (e, j) depicted more collagen type I and
aSMA than both the aorta (a) and pulmonary vessels (c) in the control hearts.
Further

confocal

imaging

was

done

using

DAPI

and

elastin

immunofluorescence staining in Figure A.4. The control aorta in part a depicted
more presence of elastin than the cyclopamine aorta in part b as indicated by
relative staining intensity. The DAPI staining for cell nuclei showed less
cellularization and less elastin staining intensity in the control pulmonary leaflets
(c) than those in the cyclopamine heart (d). More prominent elastin is shown
around the common OFT of the NCA heart (e) than the aortic and pulmonary
vessels in the control and cyclopamine hearts in parts a through d. The NCA heart
also has leaflets that appeared to be the least cellularized overall as shown by
relative blue staining intensity.
Figure A.5 shows AMIRA 3D reconstructions of serially sectioned hearts in
order to get a better understanding of the anatomical structure of each heart and
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its defects. The top row depicts the outer volume and vascular walls of control,
cyclopamine, and NCA hearts. The bottom row depicts the flow space in each
heart type. One cyclopamine heart shows pulmonary stenosis, which is classified
as partial obstruction of the pulmonary vessel whereas the other cyclopamine heart
illustrates pulmonary atresia, which is characterized as total obstruction of the
lumen of the pulmonary vessel. The NCA heart is described as persistent truncus
arteriosus. Variations in flow space and overall heart size are apparent.
A.3 DISCUSSION AND CONCLUSIONS
We have utilized two different models of CHDs to analyze tissue
morphology and create three-dimensional reconstructions of CHDs in order to
predict hemodynamic properties and to elucidate more information on the interplay
between molecular and hemodynamic influences. We employed the avian model
of TOF, characterized by ventricular septal defect, pulmonary obstruction (stenosis
or atresia), overriding aorta, and right ventricular hypertrophy, through the
inhibition of Sonic hedgehog (Shh), which reduces proliferation of the secondary
heart field (SHF). Abnormal SHF proliferation has been linked to arterial pole
defects, suggesting that cyclopamine treatment may yield arterial pole defects later
in development.57 Ablation of the NC was also used as another avian model of
CHDs that most commonly resulted in persistent truncus arteriosus (PTA) or other
OFT malalignment defects such as double outlet right ventricle and TOF.
Our results yielded a range of various cardiac malformations that showed
drastic differences in overall tissue structure and morphology, which would indicate
aberrations in hemodynamic function. We utilized a variety of methods to examine
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the range of defects present in the cyclopamine-treated and NCA hearts including
in vivo imaging, Movat’s pentachrome staining, confocal imaging, and 3D AMIRA
modeling. The pentachrome staining indicates substantial variation in collagen,
ground substance, and muscle content throughout entire sections of the hearts.
Confocal imaging defined areas with considerable differences in collagen type I,
tenascin, and aSMA, which would imply altered tissue morphology and function.
Finally, the AMIRA models allow visualization of those structural changes on a
larger scale to provide insight on the hemodynamic changes that coincide with
these specific cardiac malformations.
This

novel

approach

for

studying

cardiac

malformations

during

development has significant potential for providing further insight into the cause of
these CHDs. While further investigation is needed, especially with volumetric
analysis of the AMIRA models, we have created a unique system that allows for
multiple levels of research into CHDs.
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Figure A.1 shows the different vessel patterning for control, cyclopamine, and NCA
hearts. The control hearts (a-c) demonstrate normal vessel patterns branching
from the aorta and pulmonary arteries. The cyclopamine hearts show deviations
from normal vessel patterns including complete pulmonary atresia (d) and
pulmonary stenosis (e, f). The NCA hearts (g-i) all show PTA with varying numbers
and arrangements of vessels branching out of the common OFT.
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Figure A.2 is control, cyclopamine, and NCA hearts stained with Movat’s
Pentachrome. In general, the control hearts (a, d) have more red staining,
indicating more muscle, and dark purple to black staining for elastic fibers than the
cyclopamine and NCA hearts. The control hearts also have a well-defined
aorticopulmonary septum (APS) in comparison to the thin, poorly muscularized
APS in one cyclopamine heart (e) and the absence of the APSs in the NCA hearts
(c, f) and the other cyclopamine heart (b). The cyclopamine hearts have more
ground substance based on blue staining intensity around the aorta and pulmonary
vessels than controls.
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Figure A.3 shows confocal images of the aorta and pulmonary vessels of control
and cyclopamine hearts as well as the common OFT in NCA hearts. Both rows of
images show confocal staining of blue for cell nuclei (Dapi) and red for alpha
smooth muscle actin (aSMA). The green staining on the top row is collagen type
I, and the green staining on the bottom row is tenascin. The control aortas have a
much more uniform shape with smaller sinuses (a, f) than the cyclopamine
counterparts with less collagen type I and aSMA based on respective relative
green and red staining intensity (b). The valve leaflets in the control pulmonary
vessels also have more collagen type I (c) and tenascin staining (h) than the valve
leaflets in the cyclopamine hearts (d, i). The common OFTs in the NCA hearts (e,
j) illustrate more collagen type I and aSMA in the valve leaflets than both the control
aorta and pulmonary vessels (a, c).
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Figure A.4 shows confocal images of the aorta and pulmonary vessels of control
and cyclopamine hearts as well as the common OFT in an NCA heart. The blue
staining in these images is Dapi, which stains cell nuclei, and the green staining is
elastin. The control aorta (a) has more even elastin staining than the cyclopamine
aorta (b) as shown by relative staining intensity. The control pulmonary valve
leaflets (c) are generally less cellularized and have less elastin staining intensity
than the pulmonary leaflets of the cyclopamine heart (d). The NCA heart (e)
demonstrates more prominent elastin around the common OFT than the vessels
in the control and cyclopamine hearts (a-d) and has leaflets that are the least
cellularized overall as shown by relative blue staining intensity.
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Figure A.5 Amira 3D Reconstructions of HH42 Hearts (top row) and flow space
(bottom row). Control, cyclopamine-treated, and neural crest ablated hearts exhibit
cardiac malformations including pulmonary stenosis, pulmonary atresia, and PTA.
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